Tomorrow at 5 pm is when the embargo on ASCO abstracts is lifted. I expect that at tomorrow's event, the company will bring new, improved data not described in the abstract. Possibly, it is the reason for this event. I don't expect any C797S update, since tomorrow presentation is on 1st line NSCLC and C797S belongs to 2nd+ lines. What would be nice is an announcement of a partner.
Market Data 
Markets 
AI
